Benzinga | May 10, 2021 04:43PM EDT

Larimar Therapeutics Q1 EPS $(0.76) Up From $(1.10) YoY

Larimar Therapeutics (NASDAQ:LRMR) reported quarterly losses of $(0.76) per share. This is a 30.91 percent increase over losses of $(1.10) per share from the same period last year.